Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06744101

Comparative Evaluation of Diffusion Weighted MRI And Ultrasonography In The Detection of Breast Lesions

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
108 (actual)
Sponsor
Superior University · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study aims to conduct a comparative evaluation of Diffusion Weighted MRI (DW-MRI) and Ultrasonography (US) in detecting breast lesions. Breast cancer remains a leading cause of cancer-related deaths among women worldwide, necessitating efficient and accurate diagnostic methods. Ultrasonography, a commonly used imaging modality, provides valuable insights into breast lesions but has limitations in sensitivity and specificity.

Detailed description

Diffusion Weighted MRI, on the other hand, shows potential for higher accuracy in identifying malignant versus benign lesions due to its ability to assess tissue cellularity and integrity non-invasively. This research will involve a specified number of female participants within a defined age range, focusing on the comparative effectiveness, sensitivity, and specificity of DW-MRI and US. The findings are expected to contribute valuable insights into optimizing breast cancer diagnostic protocols, ultimately aiding in earlier detection, better patient outcomes, and possibly reducing the need for invasive biopsy procedures.

Conditions

Interventions

TypeNameDescription
RADIATIONEvaluate the effectiveness of Diffusion Weighted MRI (DWI) in detecting breast lesions.Assess the sensitivity, specificity, and diagnostic accuracy of DWI compared to Ultrasonography (USG) for benign and malignant lesions.
RADIATIONCompare Sensitivity and Specificity of DWI and USGAnalyze which modality performs better in lesion detection based on sensitivity and specificity.

Timeline

Start date
2024-02-28
Primary completion
2024-07-01
Completion
2025-03-01
First posted
2024-12-20
Last updated
2024-12-20

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06744101. Inclusion in this directory is not an endorsement.